← Eichor
Study identifier: NCT07122128 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

EVALUATION OF SALIVA AS LIQUID BIOPSY FOR EARLY DETECTION OF ORAL CANCER IN PATIENTS WITH ORAL-SUBMUCOUS FIBROSIS (OSMF)

Condition: The Study Focuses on the Saliva as Potential Source of Early Detection of Oral Cancer  ·  Sponsor: Liaquat University of Medical & Health Sciences

PhaseN/A
Planned participants1000
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersYes

About this study

Oral cancer is the top cancer in Pakistan, accounting for 27%, and it has a high mortality rate due to late-stage diagnosis. It primarily affects the lips, tongue, cheeks, and floor of the mouth. Major risk factor for oral cancer development is pan supari chhaliya chewing. Patients often develop a pre-malignant condition, oral submucous fibrosis, resulting in limited mouth opening. Thus, patients are diagnosed at an advanced level and poor survival. Therefore, saliva appears a potential mode of evaluation for early detection. This project aims to evaluate salivary cells, genes and biochemistry of the saliva among health volunteers and compare it with that of the patients with oral submucous fibrosis and oral cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Binafsha Manzoor Prof, SYed, PhD  ·  00923332749201  ·  binafsha.syed@lumhs.edu.pk

Fasiha Dr Shah, PhD  ·  00923363019144  ·  fasiha.shah@lumhs.edu.pk

Always discuss trial participation with your own doctor first.

Locations (1)

Medical Research CenterJāmshoro, Sinch, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07122128